Search for Common Molecular Genetic Markers of Nosocomial Pneumonia and Acute Respiratory Distress Syndrome
https://doi.org/10.15360/1813-9779-2015-3-24-38
Abstract
Genetic predisposition partially accounts for the clinical variability of the course of an infectious process. A total of 750 people, including 419 (81.1%) male patients aged 42.9±0.9 years, admitted to the clinics of the V. A. Negovsky Research Institute of General Reanimatology (Moscow, Russia), were genotyped to establish the influence of genetic factors on their susceptibility to critical conditions.
Materials and methods. Tetra-primer allele-specific polymerase chain reaction was used to investigate single-nucleotide polymorphisms (SNP) in the xenobiotic detoxification and oxidative stress genes (CYP1A1 (three sites), AhR, ABCB1, SOD2, GCLC and CAT) and in the vascular homeostasis genes (ACE, AGT, AGTR1, NOS3, VEGFα and MTHFR).
Results. A total of 268 nosocomial pneumonia (NP) cases were registered in a patient group. Individual SNP analysis has shown that among the patients with NP the risk of acute respiratory distress syndrome (ARDS) is associated with the carriage of the following genotypes: CYP1A1 rs2606345-Т/Т (p=0.0027, OR=2.38; 95% CI: 1.35—4.17) and AhRrs2066853-G/A-A/A (p=0.0012, OR=2.94; 95% CI: 1.54—5.60). The frequency of the C allele of the AGTR1 gene (re5186) was much higher among the survivors (in the NP group). The assessment of a multiplicative genetic model of genes that had demonstrated the highest single-locus effects because of a ARDS risk, as well as in-hospital mortality, could establish the complex genotype including a combination of risky alleles of the detoxi- fication and vascular homeostasis genes (CYP1A1 rs2606345-T — AhR rs2066853-A and ACE rs4340-D — AGT rs699-C — AGTR1 rs5186-C), which was associated with the increased risk of both NP and ARDS, as well as with the likelihood of a fatal outcome.
Conclusion. An understanding of the risk factors of NP and ARDS will aid in predicting the outcome of the underlying disease and in developing possible preventive measures.
About the Authors
T. V. SmelayaRussian Federation
Russia, 25, Petrovka St., Build. 2, Moscow 107031
A. N. Kuzovlev
Russian Federation
Russia, 25, Petrovka St., Build. 2, Moscow 107031
V. V. Moroz
Russian Federation
Russia, 25, Petrovka St., Build. 2, Moscow 107031
A. M. Golubev
Russian Federation
Russia, 25, Petrovka St., Build. 2, Moscow 107031
O. B. Belopolskaya
Russian Federation
Russia, 3, Gubkin St., Moscow 117971
L. E. Salnikova
Russian Federation
Russia, 25, Petrovka St., Build. 2, Moscow 107031
Russia, 3, Gubkin St., Moscow 117971
References
1. Yoon Y.S. Respiratory review of 2012: pneumonia. Tuberc. Respir. Dis. (Seoul). 2012; 73 (2): 77–83. http://dx.doi.org/10.4046/trd.2012.73.2.77. PMID: 23166539
2. Schuetz P., Batschwaroff M., Dusemund F., Albrich W., Bürgi U., Maurer M., Brutsche M., Huber A.R., Müller B. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections
3. outside of study conditions: a post-study survey. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29 (3): 269—277. http://dx.doi.org/10.1007/s10096-009-0851-0. PMID: 20039090
4. Мороз В.В., Смелая Т.В., Голубев А.М., Сальникова Л.Е. Генетика и медицина критических состояний: от теории к практике. Общая реаниматология. 2012; 8 (4): 5—12. http://dx.doi.org/10.15360/1813-9779-2012-4-5
5. Determann R.M., Royakkers A., Wolthuis E.K., Vlaar A.P., Choi G., Paulus F., Hofstra J.J., de Graaff M.J., Korevaar J.C., Schultz M.J. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit. Care. 2010; 14 (1): R1. http://dx.doi.org/ 10.1186/cc8230. PMID: 20055989
6. Copland I.B., Post M. Understanding the mechanisms of infant respiratory distress and chronic lung disease. Am. J. Respir. Cell Mol. Biol.
7. ; 26 (3): 261—265. http://dx.doi.org/10.1165/ajrcmb.26.3.f231.PMID: 11867331
8. Баранов В.С., Глотов О.С., Баранова Е.В. Геномика старения и предиктивная медицина. Успехи геронтологии. 2010; 23 (3): 329—338. PMID: 21137201
9. van de Vosse E., van Dissel J.T., Ottenhoff T.H. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 2009; 9 (11): 688—698. http://dx.doi.org/10.1016/S1473-3099(09)70255-5. PMID: 19850227
10. Brownson R.C., Dodson E.A., Stamatakis K.A., Casey C.M., Elliott M.B., Luke D.A., Wintrode C.G., Kreuter M.W. Communicating evidence-based information on cancer prevention to state-level policy makers. J. Natl. Cancer Inst. 2011; 103 (4): 306—316. http://dx.doi.org/10.1093/jnci/djq529. PMID: 21212381
11. Davies P.D., Yew W.W., Ganguly D., Davidow A.L., Reichman L.B., Dheda K., Rook G.A. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans. R. Soc. Trop. Med. Hyg. 2006; 100 (4): 291—298. http://dx.doi.org/10.1016/j.trstmh.2005.06.034. PMID: 16325875
12. Angus D.C., Burgner D., Wunderink R., Mira J.P., Gerlach H., Wiedermann C.J., Vincent J.L. The PIRO concept: P is for predisposition. Crit. Care. 2003; 7 (3): 248—251. PMID: 12793879
13. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M.Jr., Musher D.M., Niederman M.S., Torres A., Whitney C.G.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 Suppl 2: S27—S72. http://dx.doi.org/10.1086/511159.PMID: 17278083
14. Назаренко Г.И., Клейменова Е.Б., Гущина Н.Н. Изучение генетических маркеров и традиционных факторов риска развития ишемической болезни сердца. Рос. мед. вести. 2009; 14 (1): 47—54.
15. Christie D., Shofer J., Millard S.P., Li E., Demichele-Sweet M.A., Weamer E.A., Kamboh M.I., Lopez O.L., Sweet R.A., Tsuang D. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer’s disease is dependent on the psychosis phenotype. Behav. Brain Funct. 2012; 8: 62. http://dx.doi.org/0.1186/1744-9081-8-62. PMID: 23270420
16. Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Host genetic risk factors for community-acquired pneumonia. Gene. 2013; 518 (2): 449—456. http://dx.doi.org/ 10.1016/j.gene.2012.10.027. PMID: 23107763
17. Salnikova L.E., Smelaya T.V., Moroz V.V., Golubev A.M., Rubanovich A.V. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia. Int. J. Infect. Dis. 2013; 17 (6): e433—e442. http://dx.doi.org/10.1016/j.ijid.2013.01.005. PMID: 23411129
18. Мороз В.В., Голубев А.М. Принципы диагностики ранних проявлений острого повреждения легких. Общая реаниматология. 2006; 2 (4): 5—7. http://dx.doi.org/10.15360/1813-9779-2006-4
19. Rambaldi D., Pece S., Di Fiore P.P. Bioconductor package to estimate proliferation in cell-tracking dye studies. Bioinformatics. 2014; 30 (14): 2060—2065. http://dx.doi.org/10.1093/bioinformatics/btu127. PMID: 24681909
20. Hamajima N. PCR–CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev. Mol. Diagn. 2001; 1 (1): 119—123. PMID: 11901796
21. winSTAT.com 2003.1
22. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22 (15): 1928—1929. http://dx.doi.org/10.1093/bioinformatics/btl268. PMID: 16720584
23. Benjamini Y., Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics. 2005; 171 (2): 783—790. http://dx.doi.org/10.1534/genetics.104.036699. PMID: 15956674
24. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA. 2003; 100 (16): 9440—9445. PMID: http://dx.doi.org/10.1073/pnas.1530509100.12883005
25. Abramson J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov. 2011; 8 (1): 1. http://dx.doi.org/10.1186/1742-5573-8-1. PMID: 21288353
26. Jiang W., Welty S.E., Couroucli X.I., Barrios R., Kondraganti S.R., Muthiah K., Yu L., Avery S.E., Moorthy B. Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J. Pharmacol. Exp. Ther. 2004; 310 (2): 512—519. http://dx.doi.org/10.1124/jpet.103.059766. PMID: 15123765
27. Jiang W., Couroucli X.I., Wang L., Barrios R., Moorthy B. Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo. Biochem. Biophys. Res. Commun. 2011; 407 (1): 79—85. http://dx.doi.org/10.1016/j.bbrc.2011.02.113. PMID: 21362406
28. Rotunno M., Yu K., Lubin J.H., Consonni D., Pesatori A.C., Goldstein A.M., Goldin L.R., Wacholder S., Welch R., Burdette L., Chanock S.J., Bertazzi P.A., Tucker M.A., Caporaso N.E., Chatterjee N., Bergen A.W., Landi M.T. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One. 2009; 4 (5): e5652. http://dx.doi.org/10.1371/journal.pone.0005652. PMID: 19479063
29. Wang S., Chanock S., Tang D., Li Z., Jedrychowski W., Perera F.P. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH- DNA adducts in African American, Dominican and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers Prev. 2008; 17 (2): 405—413. http://dx.doi.org/10.1158/1055-9965. PMID: 18268125
30. Колесникова Л.И., Баирова Т.А., Первушина О.А. Гены ферментов антиоксидантной системы. Вестник РАМН. 2013; 12: 83—88. PMID: 24741948 29. Smart C.D., Mayton H., Mizubuti E.S., Willmann M.R., Fry W.E. Environmental and genetic factors influencing self-fertility in Phytophthora infestans. Phytopathology. 2000; 90 (9): 987—994. http://dx.doi.org/10.1094 /PHYTO.2000.90.9.987. PMID: 18944524
31. Zhang B., Beeghly-Fadiel A., Lu W., Cai Q., Xiang Y.B., Zheng Y., Long J., Ye C., Gu K., Shu X.O., Gao Y., Zheng W. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Am. J. Epidemiol. 2011; 173 (10): 1159—1170. http://dx.doi.org/10.1093/aje/kwr004. PMID: 21454829
32. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 309—334. PMID: 12540743
33. Busbee P.B., Rouse M., Nagarkatti M., Nagarkatti P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr. Rev. 2013; 71 (6): 353—369. http://dx.doi.org/10. 1111/nure.12024. PMID: 23731446
34. Stockinger B. Beyond toxicity: aryl hydrocarbon receptormediated functions in the immune system. J. Biol. 2009; 8 (7): 61. http://dx.doi.org/10.1186/jbiol170. PMID: 19691822
35. Rohlman D., Pham D., Yu Z., Steppan L.B., Kerkvliet N.I. Aryl hydrocarbon receptor-mediated perturbations in gene expression during early stages of CD4(+) T-cell differentiation. Front. Immunol. 2012; 6 (3): 223. http://dx.doi.org/10.3389/fimmu.2012.00223. PMID: 22888330
36. Esser C., Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 2015; 67 (2): 259—279. http://dx.doi.org/10.1124/pr.114.009001. PMID: 25657351
37. Gradman E.H. Evolving understanding of the renin–angiotensin–aldosterone system: pathophysiology and targets for therapeutic intervention. Am. Heart J. 2009; 157: S1—S6.
38. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996; 97 (8): 1916—1923. PMID: 8621776
39. Manzanares W., Dhaliwal R., Jiang X., Murch L., Heyland D.K. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit. Care. 2012; 16 (2): R66. http://dx.doi.org/10.1186/cc11316. PMID: 22534505
40. Zhou M.S., Schulman I.H., Raij L. Nitric oxide, angiotensin II, and hypertension. Semin. Nephrol. 2004; 24 (4): 366—378. PMID: 15252776 40. Ho R.H., Kim R.B. Transporters and drug therapy: implications for drug disposition and disease. Clin. Pharmacol. Ther. 2005; 78 (3): 260—277. PMID: 16153397
41. Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008; 38 (7—8): 802—832. http://dx.doi.org/10.1080/00498250701867889. PMID: 18668431
42. Weng L., Macciardi F., Subramanian A., Guffanti G., Potkin S.G., Yu Z., Xie X. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011; 12: 99. http://dx.doi.org/10.1186/1471-2105-12-99. PMID: 21496265
43. Braun R., Buetow K. Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data. PLoS Genet. 2011; 7 (6): e1002101. http://dx.doi.org/10.1371/journal.pgen.1002101. PMID: 21695280
44. Orfanos S.E., Armaganidis A., Glynos C., Psevdi E., Kaltsas P., Sarafidou P., Catravas J.D., Dafni U.G., Langleben D., Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation. 2000; 102 (16): 2011—2018. http://dx.doi.org/10.1161/01.CIR.102.16.2011. PMID: 11034953
45. Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М., Половников С.Г., Шабанов А.К., Голубев М.А. Сурфактантный протеин А (SP-A) — прогностический молекулярный биомаркер при остром респираторном дистресс-синдроме. Общая реаниматология. 2013; 9 (3): 5—13. http://dx.doi.org/10.15360/1813-9779-2013-3-5
46. Мороз В.В., Голубев А.М., Кузовлев А.Н., Писарев В.М. Новые диагностические кандидатные молекулярные биомаркеры острого респираторного дистресссиндрома. Общая реаниматология. 2014; 10 (4): 6—10. http://dx.doi.org/10.15360/1813-9779-2014-4-6-10
47. Мороз В.В., Голубев А.М., Кузовлев А.Н., Шабанов А.К., Писарев В.М. Белок клеток Клара (Club cell protein) — новый диагностический кандидатный молекулярный биомаркер при нозокомиальной пневмонии. Общая реаниматология. 2014; 10 (6): 6—14. http://dx.doi.org/10.15360/1813-9779-2014-6-6-14
Review
For citations:
Smelaya T.V., Kuzovlev A.N., Moroz V.V., Golubev A.M., Belopolskaya O.B., Salnikova L.E. Search for Common Molecular Genetic Markers of Nosocomial Pneumonia and Acute Respiratory Distress Syndrome. General Reanimatology. 2015;11(3):24-38. https://doi.org/10.15360/1813-9779-2015-3-24-38